Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting
Genetic lesions in proto-oncogenes result in the perturbation of angiogenesis, the formation of neovessels from a pre-existing microvasculature. Similarly, the subversion of tumor suppressor genes promotes tumor vascularization. Excessive neovessel formation is associated with various neoplasms such...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/4/1192 |
id |
doaj-50f38437640e4db391ff15d94a2d8280 |
---|---|
record_format |
Article |
spelling |
doaj-50f38437640e4db391ff15d94a2d82802020-11-24T21:06:41ZengMDPI AGInternational Journal of Molecular Sciences1422-00672018-04-01194119210.3390/ijms19041192ijms19041192Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic TargetingPeace Mabeta0Department of Physiology, Faculty of Health Sciences, University of Pretoria, 9 Botshelo Road, Pretoria 0007, South AfricaGenetic lesions in proto-oncogenes result in the perturbation of angiogenesis, the formation of neovessels from a pre-existing microvasculature. Similarly, the subversion of tumor suppressor genes promotes tumor vascularization. Excessive neovessel formation is associated with various neoplasms such as infantile hemangiomas (IH). Hemangiomas are the most common tumors in pediatric patients and at present have no definitive treatment. The pathogenesis of IH is not well understood; however, both vasculogenesis and angiogenesis are associated with hemangioma genesis. A number of factors that modulate angiogenesis and vasculogenesis have been shown to be dysregulated in IH. Several of the oncogenes and tumor suppressors linked to the promotion of angiogenesis are also altered in infantile hemangioma. In this review, the roles of oncogenes and tumor suppressor genes during neovascularization and hemangioma genesis are explored. In addition, the potential for targeting these genes in IH therapy is discussed.http://www.mdpi.com/1422-0067/19/4/1192angiogenesishemangiomaoncogeneoncosuppressorvascular endothelial growth factor |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peace Mabeta |
spellingShingle |
Peace Mabeta Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting International Journal of Molecular Sciences angiogenesis hemangioma oncogene oncosuppressor vascular endothelial growth factor |
author_facet |
Peace Mabeta |
author_sort |
Peace Mabeta |
title |
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting |
title_short |
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting |
title_full |
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting |
title_fullStr |
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting |
title_full_unstemmed |
Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting |
title_sort |
oncosuppressors and oncogenes: role in haemangioma genesis and potential for therapeutic targeting |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2018-04-01 |
description |
Genetic lesions in proto-oncogenes result in the perturbation of angiogenesis, the formation of neovessels from a pre-existing microvasculature. Similarly, the subversion of tumor suppressor genes promotes tumor vascularization. Excessive neovessel formation is associated with various neoplasms such as infantile hemangiomas (IH). Hemangiomas are the most common tumors in pediatric patients and at present have no definitive treatment. The pathogenesis of IH is not well understood; however, both vasculogenesis and angiogenesis are associated with hemangioma genesis. A number of factors that modulate angiogenesis and vasculogenesis have been shown to be dysregulated in IH. Several of the oncogenes and tumor suppressors linked to the promotion of angiogenesis are also altered in infantile hemangioma. In this review, the roles of oncogenes and tumor suppressor genes during neovascularization and hemangioma genesis are explored. In addition, the potential for targeting these genes in IH therapy is discussed. |
topic |
angiogenesis hemangioma oncogene oncosuppressor vascular endothelial growth factor |
url |
http://www.mdpi.com/1422-0067/19/4/1192 |
work_keys_str_mv |
AT peacemabeta oncosuppressorsandoncogenesroleinhaemangiomagenesisandpotentialfortherapeutictargeting |
_version_ |
1716765065231728640 |